Effectiveness of mRNA Booster Vaccination Against Mild, Moderate, and Severe COVID-19 Caused by the Omicron Variant in a Large, Population-Based, Norwegian Cohort.
J Infect Dis
; 226(11): 1924-1933, 2022 11 28.
Article
in En
| MEDLINE
| ID: mdl-36259543
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
Type of study:
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
J Infect Dis
Year:
2022
Type:
Article
Affiliation country:
Norway